| Jennifer Herrmann, OTD | |
|
700 Monterey Pl, Hutchinson, KS 67502-2266 | |
| (620) 694-1266 | |
| Not Available |
| Full Name | Jennifer Herrmann |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 12 Years |
| Location | 700 Monterey Pl, Hutchinson, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942608823 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 17-03025 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Empowerme Rehabilitation Missouri Llc | 9234402470 | 123 |
| Empowerme Wellness Kansas City Llc | 9830504836 | 99 |
News Archive
The Norwegian biopharmaceutical company Lytix Biopharma and the Korean biotechnology company KAEL-GemVax announced today the successful first treatment in the study of a combination of LTX-315 and GV1001 as anti-cancer vaccine therapy.
TherapeuticsMD, Inc., a women's healthcare company and parent company of vitaMedMD, announced today the launch of vitaMedMD's newest prescription prenatal multivitamin, vitaPearl, adding to its successful prenatal line consisting of vitaMedMD One Rx, vitaMedMD Plus Rx, and vitaMedMD RediChew™ Rx.
Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer's disease and related neurodegenerative disorders, and the Feinstein Institutes for Medical Research announced today the publication of preclinical data demonstrating that an oral small molecule drug inhibits the formation of neurotoxic tau oligomers in an animal model of tau aggregation most relevant to AD.
For the first time, researchers at the University of California, San Diego School of Medicine have isolated and characterized the progenitor cells that eventually give rise to malignant hepatocellular carcinoma tumors - the most common form of liver cancer. The researchers found ways to identify and isolate the HCC progenitor cells long before actual tumors were apparent.
› Verified 4 days ago
| Provider Name | Empowerme Rehabilitation Missouri Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1205334521 PECOS PAC ID: 9234402470 Enrollment ID: O20180810001282 |
News Archive
The Norwegian biopharmaceutical company Lytix Biopharma and the Korean biotechnology company KAEL-GemVax announced today the successful first treatment in the study of a combination of LTX-315 and GV1001 as anti-cancer vaccine therapy.
TherapeuticsMD, Inc., a women's healthcare company and parent company of vitaMedMD, announced today the launch of vitaMedMD's newest prescription prenatal multivitamin, vitaPearl, adding to its successful prenatal line consisting of vitaMedMD One Rx, vitaMedMD Plus Rx, and vitaMedMD RediChew™ Rx.
Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer's disease and related neurodegenerative disorders, and the Feinstein Institutes for Medical Research announced today the publication of preclinical data demonstrating that an oral small molecule drug inhibits the formation of neurotoxic tau oligomers in an animal model of tau aggregation most relevant to AD.
For the first time, researchers at the University of California, San Diego School of Medicine have isolated and characterized the progenitor cells that eventually give rise to malignant hepatocellular carcinoma tumors - the most common form of liver cancer. The researchers found ways to identify and isolate the HCC progenitor cells long before actual tumors were apparent.
› Verified 4 days ago
| Provider Name | Empowerme Wellness Kansas City Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1124619697 PECOS PAC ID: 9830504836 Enrollment ID: O20210304001079 |
News Archive
The Norwegian biopharmaceutical company Lytix Biopharma and the Korean biotechnology company KAEL-GemVax announced today the successful first treatment in the study of a combination of LTX-315 and GV1001 as anti-cancer vaccine therapy.
TherapeuticsMD, Inc., a women's healthcare company and parent company of vitaMedMD, announced today the launch of vitaMedMD's newest prescription prenatal multivitamin, vitaPearl, adding to its successful prenatal line consisting of vitaMedMD One Rx, vitaMedMD Plus Rx, and vitaMedMD RediChew™ Rx.
Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer's disease and related neurodegenerative disorders, and the Feinstein Institutes for Medical Research announced today the publication of preclinical data demonstrating that an oral small molecule drug inhibits the formation of neurotoxic tau oligomers in an animal model of tau aggregation most relevant to AD.
For the first time, researchers at the University of California, San Diego School of Medicine have isolated and characterized the progenitor cells that eventually give rise to malignant hepatocellular carcinoma tumors - the most common form of liver cancer. The researchers found ways to identify and isolate the HCC progenitor cells long before actual tumors were apparent.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Herrmann, OTD Po Box 24066, Overland Park, KS 66283-4066 Ph: (515) 689-0854 | Jennifer Herrmann, OTD 700 Monterey Pl, Hutchinson, KS 67502-2266 Ph: (620) 694-1266 |
News Archive
The Norwegian biopharmaceutical company Lytix Biopharma and the Korean biotechnology company KAEL-GemVax announced today the successful first treatment in the study of a combination of LTX-315 and GV1001 as anti-cancer vaccine therapy.
TherapeuticsMD, Inc., a women's healthcare company and parent company of vitaMedMD, announced today the launch of vitaMedMD's newest prescription prenatal multivitamin, vitaPearl, adding to its successful prenatal line consisting of vitaMedMD One Rx, vitaMedMD Plus Rx, and vitaMedMD RediChew™ Rx.
Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer's disease and related neurodegenerative disorders, and the Feinstein Institutes for Medical Research announced today the publication of preclinical data demonstrating that an oral small molecule drug inhibits the formation of neurotoxic tau oligomers in an animal model of tau aggregation most relevant to AD.
For the first time, researchers at the University of California, San Diego School of Medicine have isolated and characterized the progenitor cells that eventually give rise to malignant hepatocellular carcinoma tumors - the most common form of liver cancer. The researchers found ways to identify and isolate the HCC progenitor cells long before actual tumors were apparent.
› Verified 4 days ago
Mr. Kalwant Singh, 0.T.R.L. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2504 Westminster Dr, Hutchinson, KS 67502 Phone: 620-663-8899 Fax: 620-665-6263 | |
Utakarsh Malge, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1415 N Monroe St, Hutchinson, KS 67501 Phone: 620-664-1975 | |
Ms. Ruth Elaine Buell, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1202 East 23rd St., Hutchinson, KS 67502 Phone: 620-669-5241 | |
Mrs. Rebecca Jo Ramirez, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3520 Prairie Hills Dr, Hutchinson, KS 67502 Phone: 620-663-6597 | |
Kendra Leigh Bowen, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1202 E 23rd Ave, Hutchinson, KS 67502 Phone: 620-669-9393 | |
Ms. Lynn Suzanne Winegardner, O.T.R. C.H.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1500 E 11th Ave, Hutchinson, KS 67501 Phone: 620-662-7226 | |
Mrs. Elisha A Katz, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 2803 N Lorraine St Ste F, Hutchinson, KS 67502 Phone: 620-662-3111 Fax: 620-662-3122 |